Beximco Pharmaceuticals (BXP.L): Commercial agreement with Mylan | ReNeuron Group (RENE.L): Positive Phase 2 data
24 Feb 2020
SP Angel Healthcare Conditions
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
SP Angel Healthcare Conditions
Beximco Pharmaceuticals Limited Sponsored GDR RegS (BXP:LON), 37.0 | ReNeuron Group plc (RENE:LON), 3.0
- Published:
24 Feb 2020 -
Author:
Vadim Alexandre | Liam Gascoigne-Cohen -
Pages:
3
Beximco Pharmaceuticals (BXP.L): Commercial agreement with Mylan | ReNeuron Group (RENE.L): Positive Phase 2 data